中华耳鼻咽喉头颈外科杂志
中華耳鼻嚥喉頭頸外科雜誌
중화이비인후두경외과잡지
CHINESE JOURNAL OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY
2009年
1期
40-43
,共4页
曾泉%唐平章%徐震纲%祁永发%吴雪溪%刘文胜
曾泉%唐平章%徐震綱%祁永髮%吳雪溪%劉文勝
증천%당평장%서진강%기영발%오설계%류문성
喉肿瘤%涎腺%肿瘤%预后
喉腫瘤%涎腺%腫瘤%預後
후종류%연선%종류%예후
Laryngeal neoplasms%Salivary glands,neoplasms%Prognosis
目的 探讨喉小涎腺癌的临床特点、治疗及预后.方法 回顾性分析中国医学科学院肿瘤医院头颈外科1959至2005年收治的15例喉小涎腺癌患者的临床资料.11例(73.3%)病变位于声门上区,4例(26.7%)病变位于声门下区.其中腺样囊性癌10例,腺癌2例,黏液表皮样癌、恶性混合瘤、基底细胞腺癌各1例.单独手术7例;手术+放疗7例,其中6例患者行术后放疗,1例行术前放疗;1例行放疗+化疗.治疗后4例局部复发患者行手术挽救,其中l例肺转移后行转移灶切除;1例治疗后颈转移患者行放疗.结果 随访时间2~16年,中位数为8年.治疗后局部复发4例次,颈淋巴转移1例次,远处转移5例次,其中局部复发伴远处转移3例.7例患者存活3~16年,其中5例为无瘤生存,1例行单纯手术治疗,4例行手术+放疗;4例远处转移于治疗2~10年后死亡;其余4例随访2~16年后失访.结论 喉小涎腺癌很少见,其易发生局部复发和远处转移,远处转移是最主要的死亡原因.外科手术是喉小涎腺癌的主要治疗方法 ,手术结合放疗可望提高肿瘤局部控制率.
目的 探討喉小涎腺癌的臨床特點、治療及預後.方法 迴顧性分析中國醫學科學院腫瘤醫院頭頸外科1959至2005年收治的15例喉小涎腺癌患者的臨床資料.11例(73.3%)病變位于聲門上區,4例(26.7%)病變位于聲門下區.其中腺樣囊性癌10例,腺癌2例,黏液錶皮樣癌、噁性混閤瘤、基底細胞腺癌各1例.單獨手術7例;手術+放療7例,其中6例患者行術後放療,1例行術前放療;1例行放療+化療.治療後4例跼部複髮患者行手術輓救,其中l例肺轉移後行轉移竈切除;1例治療後頸轉移患者行放療.結果 隨訪時間2~16年,中位數為8年.治療後跼部複髮4例次,頸淋巴轉移1例次,遠處轉移5例次,其中跼部複髮伴遠處轉移3例.7例患者存活3~16年,其中5例為無瘤生存,1例行單純手術治療,4例行手術+放療;4例遠處轉移于治療2~10年後死亡;其餘4例隨訪2~16年後失訪.結論 喉小涎腺癌很少見,其易髮生跼部複髮和遠處轉移,遠處轉移是最主要的死亡原因.外科手術是喉小涎腺癌的主要治療方法 ,手術結閤放療可望提高腫瘤跼部控製率.
목적 탐토후소연선암적림상특점、치료급예후.방법 회고성분석중국의학과학원종류의원두경외과1959지2005년수치적15례후소연선암환자적림상자료.11례(73.3%)병변위우성문상구,4례(26.7%)병변위우성문하구.기중선양낭성암10례,선암2례,점액표피양암、악성혼합류、기저세포선암각1례.단독수술7례;수술+방료7례,기중6례환자행술후방료,1례행술전방료;1례행방료+화료.치료후4례국부복발환자행수술만구,기중l례폐전이후행전이조절제;1례치료후경전이환자행방료.결과 수방시간2~16년,중위수위8년.치료후국부복발4례차,경림파전이1례차,원처전이5례차,기중국부복발반원처전이3례.7례환자존활3~16년,기중5례위무류생존,1례행단순수술치료,4례행수술+방료;4례원처전이우치료2~10년후사망;기여4례수방2~16년후실방.결론 후소연선암흔소견,기역발생국부복발화원처전이,원처전이시최주요적사망원인.외과수술시후소연선암적주요치료방법 ,수술결합방료가망제고종류국부공제솔.
Objective To study the clinical features, treatment and prognosis of malignant minor salivary gland tumors of the larynx. Methods Treatment and outcome were retrospectively analyzed in a consecutive series of 15 patients with malignant minor salivary gland tumors of the larynx treated in this hospital from 1959 to 2005. Ten patients (66.7%) had adenoid cystic carcinoma and 2 (13.3%) had adenocarcinoma. The other three patients had mucoepidermoid carcinomas, polymorphic adenocarcinoma and base cell carcinoma respectively. Eleven(73.3%) were located in the supraglottis and 4 (26.7%) in the subglottis. Fourteen had surgery (7 with adjuvant radiotherapy) and one was treated with radiotherapy plus chemotherapy. Five patients were found to have recurrent disease, 4 of whom underwent salvage surgery, 1 of whom had pallitation radiotherapy. Results With a median follow-up of 8 years (ranging from 2 to 16 years), 7 patients are alive. Five patients have no evidence of disease, 1 of whom had surgery alone,4 of whom were treated with surgery plus radiotherapy. Four patients died of distant metastases in a range of 2 to 10 years. The other 4 patients were lost to follow-up after treatment(ranging from 2 years to 16 years). Seven patients developed recurrent disease, 1 of whom had local recurrence alone, 1 had regional recurrence alone, 2 had distant metastases alone, and 3 had local and distant metastases. Conclusions Minor salivary gland carcinomas of the larynx are rare and they are prone to the local recurrence and the distant metastasis in advanced stage. Distant metastases remain the principal cause of treatment failure. Surgery is the primary treatment modality used in most cases and the radiotherapy combining surgery has better local and regional control rate.